ARTICLE | Company News
Oxford BioTherapeutics board of directors update
December 14, 2009 8:00 AM UTC
Oxford BioTherapeutics Ltd., Abingdon, U.K. Business: Cancer, Proteomics, Supply/Service Appointed: Michael Moore as non-executive chairman, formerly CEO of Piramed Ltd. (now part of Roche) ...